These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1451735)

  • 21. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated administration of SCH 23390 enhances the SKF 38393-induced inhibition in the rat hippocampus.
    Smiałowski A; Bijak M
    Neuroscience; 1989; 28(2):409-12. PubMed ID: 2564173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
    Shieh GJ; Walters DE
    Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors.
    al-Tajir G; Starr MS; Starr BS
    Eur J Pharmacol; 1990 Jul; 182(2):245-51. PubMed ID: 2204536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
    Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
    Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation.
    Trugman JM; James CL
    Brain Res; 1993 Apr; 607(1-2):270-4. PubMed ID: 8481802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.
    O'Sullivan GJ; Dunleavy M; Hakansson K; Clementi M; Kinsella A; Croke DT; Drago J; Fienberg AA; Greengard P; Sibley DR; Fisone G; Henshall DC; Waddington JL
    Neuropharmacology; 2008 Jun; 54(7):1051-61. PubMed ID: 18367215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of dopamine D1 receptors enhances long-term depression of synaptic transmission induced by low frequency stimulation in rat hippocampal CA1 neurons.
    Chen Z; Fujii S; Ito K; Kato H; Kaneko K; Miyakawa H
    Neurosci Lett; 1995 Mar; 188(3):195-8. PubMed ID: 7609907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    Witkin JM; Newman AH; Nowak G; Katz JL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of c-fos protein in the experimental epilepsy induced by pilocarpine.
    Barone P; Morelli M; Cicarelli G; Cozzolino A; DeJoanna G; Campanella G; DiChiara G
    Synapse; 1993 May; 14(1):1-9. PubMed ID: 8511714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
    Imperato A; Obinu MC; Gessa GL
    Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of D1 receptors in depression-like behavior of ovariectomized rats.
    Fedotova J; Ordyan N
    Acta Physiol Hung; 2011 Jun; 98(2):165-76. PubMed ID: 21616775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.